Galderisi U; Jori FP; Giordano A. Cell cycle regulation and neural differentiation. Oncogene. August 2003, 22 (33): 5208–19. PMID 12910258. doi:10.1038/sj.onc.1206558.
Brown NR, Noble ME, Endicott JA, Garman EF, Wakatsuki S, Mitchell E, Rasmussen B, Hunt T, Johnson LN. The crystal structure of cyclin A. Structure. November 1995, 3 (11): 1235–47. PMID 8591034. doi:10.1016/S0969-2126(01)00259-3.
Davies TG, Tunnah P, Meijer L, Marko D, Eisenbrand G, Endicott JA, Noble ME. Inhibitor binding to active and inactive CDK2: the crystal structure of CDK2-cyclin A/indirubin-5-sulphonate. Structure. May 2001, 9 (5): 389–97. PMID 11377199. doi:10.1016/S0969-2126(01)00598-6.
Fung TK, Poon RY. A roller coaster ride with the mitotic cyclins. Seminars in Cell & Developmental Biology. June 2005, 16 (3): 335–42. PMID 15840442. doi:10.1016/j.semcdb.2005.02.014.
Rahman MM, Kipreos ET. The specific roles of mitotic cyclins revealed. Cell Cycle. January 2010, 9 (1): 22–3. PMID 20016257. doi:10.4161/cc.9.1.10577.
nih.gov
ncbi.nlm.nih.gov
Galderisi U; Jori FP; Giordano A. Cell cycle regulation and neural differentiation. Oncogene. August 2003, 22 (33): 5208–19. PMID 12910258. doi:10.1038/sj.onc.1206558.
Brown NR, Noble ME, Endicott JA, Garman EF, Wakatsuki S, Mitchell E, Rasmussen B, Hunt T, Johnson LN. The crystal structure of cyclin A. Structure. November 1995, 3 (11): 1235–47. PMID 8591034. doi:10.1016/S0969-2126(01)00259-3.
Davies TG, Tunnah P, Meijer L, Marko D, Eisenbrand G, Endicott JA, Noble ME. Inhibitor binding to active and inactive CDK2: the crystal structure of CDK2-cyclin A/indirubin-5-sulphonate. Structure. May 2001, 9 (5): 389–97. PMID 11377199. doi:10.1016/S0969-2126(01)00598-6.
Fung TK, Poon RY. A roller coaster ride with the mitotic cyclins. Seminars in Cell & Developmental Biology. June 2005, 16 (3): 335–42. PMID 15840442. doi:10.1016/j.semcdb.2005.02.014.